HyperQ Resting is an innovative cardiac diagnostic technology designed to evaluate the risk of coronary artery disease (CAD), a prevalent cardiovascular condition characterized by the narrowing of the coronary arteries that supply blood to the heart. This non-invasive tool offers valuable insights into cardiac health, aiding in early detection and risk assessment.

The procedure involves attaching electrodes to the patient’s chest to record the heart’s electrical activity during rest. HyperQ Resting is particularly sensitive to subtle electrical changes that can indicate myocardial ischemia, a condition where the heart muscle receives inadequate blood flow and oxygen. Early detection of ischemia is crucial, as it can lead to timely intervention and prevent severe cardiac events.

HyperQ Resting offers several advantages:

1. Early Detection: It can identify cardiac abnormalities before symptoms become evident, enabling early intervention and reducing the risk of heart attacks.
2. Non-Invasive: The procedure is painless and non-invasive, requiring no injections or radiation exposure.
3. Risk Assessment: It provides an accurate assessment of the patient’s risk for CAD, guiding healthcare providers in developing personalized treatment plans.
4. Monitoring: HyperQ Resting can be used to monitor changes in cardiac health over time, helping with long-term management.

This diagnostic tool has significantly improved the early detection and management of coronary artery disease, contributing to better patient outcomes and enhanced cardiac care. It complements other cardiac tests and evaluations, assisting healthcare professionals in delivering comprehensive cardiovascular care.